Masimo Debt to Equity Ratio 2007-2018 | MASI

Current and historical debt to equity ratio values for Masimo (MASI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Masimo debt/equity for the three months ending September 30, 2018 was 0.00.
Masimo Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $0.91B 0.00
2018-06-30 $0.00B $0.83B 0.00
2018-03-31 $0.00B $0.77B 0.00
2017-12-31 $0.00B $0.72B 0.00
2017-09-30 $0.00B $0.72B 0.00
2017-06-30 $0.00B $0.71B 0.00
2017-03-31 $0.00B $0.63B 0.00
2016-12-31 $0.00B $0.56B 0.00
2016-09-30 $0.15B $0.33B 0.46
2016-06-30 $0.18B $0.30B 0.59
2016-03-31 $0.23B $0.27B 0.84
2015-12-31 $0.19B $0.28B 0.67
2015-09-30 $0.19B $0.27B 0.71
2015-06-30 $0.18B $0.28B 0.63
2015-03-31 $0.13B $0.33B 0.39
2014-12-31 $0.13B $0.31B 0.41
2014-09-30 $0.00B $0.28B 0.00
2014-06-30 $0.00B $0.32B 0.00
2014-03-31 $0.00B $0.35B 0.00
2013-12-31 $0.00B $0.33B 0.00
2013-09-30 $0.00B $0.31B 0.00
2013-06-30 $0.00B $0.29B 0.00
2013-03-31 $0.00B $0.28B 0.00
2012-12-31 $0.00B $0.28B 0.00
2012-09-30 $0.00B $0.31B 0.00
2012-06-30 $0.00B $0.30B 0.00
2012-03-31 $0.00B $0.28B 0.00
2011-12-31 $0.00B $0.28B 0.00
2011-09-30 $0.00B $0.30B 0.00
2011-06-30 $0.00B $0.28B 0.00
2011-03-31 $0.00B $0.26B 0.00
2010-12-31 $0.00B $0.23B 0.00
2010-09-30 $0.00B $0.25B 0.00
2010-06-30 $0.00B $0.23B 0.00
2010-03-31 $0.00B $0.21B 0.00
2009-12-31 $0.00B $0.29B 0.00
2009-09-30 $0.00B $0.27B 0.00
2009-06-30 $0.00B $0.25B 0.00
2009-03-31 $0.00B $0.24B 0.00
2008-12-31 $0.00B $0.22B 0.00
2008-09-30 $0.00B $0.21B 0.00
2008-06-30 $0.00B $0.19B 0.00
2008-03-31 $0.00B $0.17B 0.00
2007-12-31 $0.02B $0.15B 0.13
2007-09-30 $0.02B $0.14B 0.16
2007-06-30 $0.03B $-0.02B -1.67
2007-03-31 $0.00B $0.00B 0.00
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.866B $0.798B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $100.978B 22.56
Intuitive Surgical (ISRG) United States $62.759B 59.07
Edwards Lifesciences (EW) United States $36.781B 37.67
Fresenius Medical Care AG KGaA (FMS) Germany $23.554B 15.93
IDEXX Laboratories (IDXX) United States $18.175B 49.49
ABIOMED (ABMD) United States $16.202B 106.96
Hologic (HOLX) United States $13.485B 20.39
DexCom (DXCM) United States $13.140B 0.00
Teleflex (TFX) United States $12.967B 29.44
Varian Medical Systems (VAR) United States $11.956B 29.87
STERIS (STE) United Kingdom $10.363B 26.63
Penumbra (PEN) United States $5.218B 315.06
LivaNova (LIVN) United Kingdom $4.825B 30.97
Globus Medical (GMED) United States $4.690B 29.40
Integra LifeSciences Holdings (IART) United States $4.359B 21.23
Wright Medical Group (WMGI) Netherlands $3.944B 0.00
Cantel Medical (CMD) United States $3.543B 34.94
Inogen (INGN) United States $2.977B 64.26
Tandem Diabetes Care (TNDM) United States $2.881B 0.00
Integer Holdings (ITGR) United States $2.678B 22.42
Glaukos (GKOS) United States $2.441B 0.00
AVANOS MEDICAL, INC (AVNS) United States $2.342B 21.11
OPKO Health (OPK) United States $1.653B 0.00
Nevro (NVRO) United States $1.426B 0.00
Tactile Systems Technology (TCMD) United States $1.369B 217.97
ORTHOFIX MEDICAL INC (OFIX) United States $1.239B 35.78
Luminex (LMNX) United States $1.155B 52.86
Pacific Biosciences Of California (PACB) United States $1.074B 0.00
CryoLife (CRY) United States $1.066B 115.36
Accelerate Diagnostics (AXDX) United States $1.055B 0.00
Intersect ENT (XENT) United States $1.047B 0.00
Natus Medical (BABY) United States $0.931B 19.42
Mesa Laboratories (MLAB) United States $0.901B 36.84
AngioDynamics (ANGO) United States $0.866B 28.08
ViewRay (VRAY) United States $0.786B 0.00
Veracyte (VCYT) United States $0.752B 0.00
AxoGen (AXGN) United States $0.676B 0.00
Quotient (QTNT) Switzerland $0.639B 0.00
TransEnterix (TRXC) United States $0.596B 0.00
OrthoPediatrics (KIDS) United States $0.481B 0.00
Si-Bone (SIBN) United States $0.460B 0.00
Accuray (ARAY) United States $0.448B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.442B 0.00
Fluidigm (FLDM) United States $0.402B 0.00
GenMark Diagnostics (GNMK) United States $0.350B 0.00
Pulse Biosciences (PLSE) United States $0.338B 0.00
SeaSpine Holdings (SPNE) United States $0.313B 0.00
Neuronetics (STIM) United States $0.303B 0.00
Sientra (SIEN) United States $0.295B 0.00
RTI Surgical (RTIX) United States $0.291B 46.80
IRadimed (IRMD) United States $0.284B 60.35
Corindus Vascular Robotics (CVRS) United States $0.253B 0.00
Nuvectra (NVTR) United States $0.251B 0.00
CRH Medical (CRHM) Canada $0.239B 41.63
Helius Medical Technologies (HSDT) United States $0.177B 0.00
T2 Biosystems (TTOO) United States $0.165B 0.00
Ekso Bionics Holdings (EKSO) United States $0.135B 0.00
Sensus Healthcare (SRTS) United States $0.119B 0.00
Titan Medical (TMDI) Canada $0.098B 0.00
Ra Medical Systems (RMED) United States $0.093B 0.00
ConforMIS (CFMS) United States $0.085B 0.00
Biosig Technologies (BSGM) United States $0.085B 0.00
EDAP TMS (EDAP) France $0.079B 0.00
Apollo Endosurgery (APEN) United States $0.074B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.072B 0.00
Alphatec Holdings (ATEC) United States $0.061B 0.00
Vermillion (VRML) United States $0.060B 0.00
Second Sight Medical Products (EYES) United States $0.057B 0.00
OBALON THERPTCS (OBLN) United States $0.048B 0.00
Electromed (ELMD) United States $0.048B 24.74
Xtant Medical Holdings (XTNT) United States $0.044B 0.00
Microbot Medical (MBOT) United States $0.039B 0.00
Viveve Medical (VIVE) United States $0.034B 0.00
Restoration Robotics (HAIR) United States $0.032B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.030B 0.00
PAVmed (PAVM) United States $0.027B 0.00
Lianluo Smart (LLIT) China $0.024B 0.00
DarioHealth (DRIO) Israel $0.024B 0.00
ReWalk Robotics (RWLK) Israel $0.023B 0.00
Neovasc (NVCN) Canada $0.019B 0.00
Dynatronics (DYNT) United States $0.018B 0.00
American Shared Hospital Services (AMS) United States $0.015B 11.09
Bioanalytical Systems (BASI) United States $0.015B 47.00
Nanovibronix (NAOV) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Avinger (AVGR) United States $0.011B 0.00
Presbia (LENS) Ireland $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00